View Report Details Global HCV Market Report ----------------------------------------2016
View Report Details Executive Summary
The Hepatitis C virus (HCV) is an infection which affects the liver which may lead to serious consequences if not taken care of. It spreads through infected blood transfusions and poorly sterilized medical equipments. The number of patients has increased significantly because its symptoms take time to be recognized before the patient progresses towards a clinically visible liver damage which worsens the situation since it may lead to liver damage or even failure. There was no proper therapy for HCV before 2010 but the coming of therapies like Sovaldi and Harvoni by Gilead and Viekira Pak by AbbVie has improved the scenario. Also the steps taken like proper blood screening is also helping in identifying the patients. This is also caused because of the regular alcoholic consumption and taking drugs.
The key factors which are anticipated to drive HCV market include comfort of reimbursement given because of the therapy being very costly, growth in the number of patients, relatively smaller period of drug treatment from before, treatment of the warehoused patients who were waiting for a better therapy and pricing discounts and better regimens because of the increased competition. Some of the significant developments of this industry include launch of the interferon free regimen and development of products like Sovaldi, Harvoni and Viekira Pak and the newly identified and diagnosed patients. However, the challenges to be faced ahead is more number of patients asking for reimbursement, increasing competition leading to price cutting, risk associated with drug development and regulatory risk.
This report offers a comprehensive analysis of the HCV market. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global HCV market is reined by few major players namely Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Development of new therapies and increase of new patients to impact the HCV market.. Global HCV Sales by Value (2011-2015) The global HCV sales has increased from US$... million in 2014 to US$... million in 2015 and is expected to increase further.
US$ Million
The global deaths caused because of HCV increased to …in 2014 from …in 2013. As of 2014 in the US, the total number of patients in which HCV was prevalent was about …and the number of patients diagnosed with HCV was …. There are an estimated …number of patients to be treated in the US in 2015. 2011
2012
2013
2014
2015
Global Deaths due to HCV (2010-2014)
Millions
Estimated Patients (In Million)
US HCV Market Dynamics (2014)
Prevalence
Diagnosed
Under Treatment
2010
2011
2012
2013
2014
Treated
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
HCV market is witnessing increase in the number of warehoused patients and also increase in healthcare expenditure . EU (European Union) HCV Sales by Value (2011-2015)
In 2014, the HCV sales in European Union (EU) reached US$... million in comparison to US$.... million in 2013.
US$ Million
The global healthcare expenditure increased from …trillion in 2007 to … trillion in 2014 . The global old population increased from …million in 2006 to … million in 2014. It is estimated that around …% of the warehouse patients were treated in 2014.. 2011
2012
2013
2014
2015
Global Healthcare Expenditure (2007-2014)
US$ Trillion
Million
Global Old Population (2006- 2014)
2006 2007
2008
2009
2010
2011
2012
2013
2014
2007
2008
2009
2010
2011
2012
2013
2014
The future outlook of the HCV market would mainly be driven by development of new products like Sovaldi, Harvoni and Viekira Pak.
US$ Million
HCV Market Forecast (2014-2019E)
2014
2015
2016E
2017E
2018E
2019E
The HCV market is poised to grow at a compounded annual growth rate of …% from US$... million in 2014 to US$... million in 2019. Comfort of reimbursement, growth in the number of patients, increased healthcare expenditure, treatment of warehoused patients, pricing discount and better regimen, development of new therapies are likely the drivers of HCV market Increased competition and regulatory risk have posed a major threat for this industry.
Contact Us: Details View Report These are abridged and sanitized sample pages from the comprehensive report on the “ Global HCV Market ”. To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com